Hydroxypioglitazone,
146062-44-4,
Hydroxy Pioglitazone (M-IV),
CHEBI:82937,
2,4-Thiazolidinedione, 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-,
A1-01710,
M-IV,
2,4-Thiazolidinedione, 5-((4-(2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy)phenyl)methyl)-,
AC1N5NL9,
CHEMBL1267,
SCHEMBL4098326,
CTK8D3795,
DTXSID30399914,
MIN-102,
OXVFDZYQLGRLCD-UHFFFAOYSA-N,
ZINC01482947,
AKOS015856344,
RTC-071626,
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
Hydroxy Pioglitazone (M-IV Metabolite),
AN-31397,
TC-071626,
FT-0643388,
062H444,
C-35591,
U-91322,
J-008187,
I14-41525,
2,4-Thiazolidinedione,5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-,
5-(4-(2-(5-(1-hydroxyethyl)pyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione,
5-(4-{2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione,
5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione,
5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridyl]ethoxy]phenyl]methyl]thiazolidine-2,4-dione,
5-[4-[2-[5-(1-hydroxyethyl)-2-pyridyl]ethoxy]benzyl]-2,4-thiazolidinedione,
UNII-K824X25AYA,
K824X25AYA,
CID4147757,
CS-T-28393,